Neovascular Age Related Macular Degeneration Nvamd clinical trials

Explore recruiting neovascular age related macular degeneration nvamd clinical trials.

Recruiting neovascular age related macular degeneration nvamd studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Neovascular Age Related Macular Degeneration Nvamd trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A randomized double-masked, multicenter, 3-arm, pivotal Phase 2/3 study to evaluate the efficacy and safety of intravitreal (IVT) EYE201/MK-8748 compared to aflibercept (2 mg) in participants with neovascular age-related macular degeneration (NVAMD)

Spain, Poland, Estonia, Latvia, Germany

Phase II and Phase III (Integrated) EU CTIS Study details

A randomized double-masked, multicenter, 3-arm, pivotal Phase 2/3 study to evaluate the efficacy and safety of intravitreal (IVT) EYE201/MK-8748 compared to aflibercept (2 mg) in participants with neovascular age-related macular degeneration (NVAMD)

Austria, Slovakia, Portugal, Czechia, Hungary, Spain +4 more

Phase II and Phase III (Integrated) EU CTIS Study details

Neovascular Age Related Macular Degeneration Nvamd trials by city

Neovascular Age Related Macular Degeneration Nvamd in Toronto Neovascular Age Related Macular Degeneration Nvamd in Vancouver Neovascular Age Related Macular Degeneration Nvamd in Montreal Neovascular Age Related Macular Degeneration Nvamd in Calgary Neovascular Age Related Macular Degeneration Nvamd in Edmonton Neovascular Age Related Macular Degeneration Nvamd in Ottawa Neovascular Age Related Macular Degeneration Nvamd in Winnipeg Neovascular Age Related Macular Degeneration Nvamd in Quebec City Neovascular Age Related Macular Degeneration Nvamd in Hamilton Neovascular Age Related Macular Degeneration Nvamd in Kitchener Neovascular Age Related Macular Degeneration Nvamd in London Neovascular Age Related Macular Degeneration Nvamd in Halifax Neovascular Age Related Macular Degeneration Nvamd in New York Neovascular Age Related Macular Degeneration Nvamd in Los Angeles Neovascular Age Related Macular Degeneration Nvamd in Chicago Neovascular Age Related Macular Degeneration Nvamd in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease